Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_assertion type Assertion NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_head.
- NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_assertion description "[We demonstrate efficacy and safety of concomitant treatment with rapamycin and sorafenib at inhibiting growth of xenografts from CRC cells with coexistent mutations in KRAS and PIK3CA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_provenance.
- NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_assertion evidence source_evidence_literature NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_provenance.
- NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_assertion SIO_000772 22696593 NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_provenance.
- NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_assertion wasDerivedFrom befree-2016 NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_provenance.
- NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_assertion wasGeneratedBy ECO_0000203 NP989983.RAjuk2ighXj3-LCS9fX2j7MqcVgcmeT9cqzYLKb2FBmzo130_provenance.